Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection

PHASE2TerminatedINTERVENTIONAL

Enrollment

153

Participants

Timeline

Start Date

May 22, 2021

Primary Completion Date

August 29, 2023

Study Completion Date

August 29, 2023

Conditions

Onchocerciasis

Interventions

DRUG

ABBV-4083

Oral Capsule

DRUG

Placebo for ABBV-4083

Oral Capsule

DRUG

Albendazole

Oral encapsulated tablets

DRUG

Placebo for Albendazole

Oral Capsule

Trial Locations (2)

Hôpital Général de Référence de Kimpese, Kimpese

Hôpital Général de Référence de Masi-Manimba, Masi-Manimba